Li Xiang, Ph.D., postdoctoral scholar at the OHSU Knight Cancer Institute, and Michael Henderson, B.A., a biomedical engineering Ph.D. student, are part of a research team at Oregon Health & Science University that developed a new nanoparticle designed to make cancer treatment safer and more effective. (OHSU/Christine Torres Hicks)